BDBM50070010 4-((2R,3R)-1-Benzylcarbamoyl-3-methyl-4-oxo-azetidin-2-yloxy)-benzoic acid::CHEMBL122575

SMILES C[C@@H]1[C@@H](Oc2ccc(cc2)C(O)=O)N(C(=O)NCc2ccccc2)C1=O

InChI Key InChIKey=BRYGRWNTDBRNDJ-YVEFUNNKSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50070010   

TargetChymotrypsinogen A(Bos taurus (bovine))
Glaxo Wellcome Research And Development

Curated by ChEMBL
LigandPNGBDBM50070010(4-((2R,3R)-1-Benzylcarbamoyl-3-methyl-4-oxo-azetid...)
Affinity DataIC50:  1.60E+3nMAssay Description:Concentration of the compound required to inhibit the mammalian Chymotrypsinogen by 50% was determinedMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCapsid scaffolding protein(Human cytomegalovirus (strain AD169) (HHV-5) (Huma...)
Glaxo Wellcome Research And Development

Curated by ChEMBL
LigandPNGBDBM50070010(4-((2R,3R)-1-Benzylcarbamoyl-3-methyl-4-oxo-azetid...)
Affinity DataIC50:  2.00E+4nMAssay Description:Concentration of the compound required to inhibit the mutant alpha-Ala HCMV protease by 50% was determinedMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Glaxo Wellcome Research And Development

Curated by ChEMBL
LigandPNGBDBM50070010(4-((2R,3R)-1-Benzylcarbamoyl-3-methyl-4-oxo-azetid...)
Affinity DataIC50: >1.00E+5nMAssay Description:Concentration of the compound required to inhibit the mammalian Acetylcholinesterase by 50% was determinedMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed